Cargando…

Exploring Theranostic Potentials of Radioiodinated Hypericin in Rodent Necrosis Models

Objectives: The present animal experiments were conducted to evaluate radioiodinated Hypericin (Hyp) for its regional distribution as well as theranostic potentials. Materials and Methods: Rat models of reperfused liver infarction (RLI) and hepatic rhabdomyosarcoma (R1) were surgically induced. R1 m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Junjie, Cona, Marlein Miranda, Chen, Feng, Feng, Yuanbo, Zhou, Lin, Yu, Jie, Nuyts, Johan, de Witte, Peter, Zhang, Jian, Himmelreich, Uwe, Verbruggen, Alfons, Ni, Yicheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2012
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493203/ https://www.ncbi.nlm.nih.gov/pubmed/23139728 http://dx.doi.org/10.7150/thno.4924

Ejemplares similares

Sequential Systemic Administrations of Combretastatin A4 Phosphate and Radioiodinated Hypericin Exert Synergistic Targeted Theranostic Effects with Prolonged Survival on SCID Mice Carrying Bifocal Tumor Xenografts
por: Li, Junjie, et al.
Publicado: (2013)

Necrosis Avidity: A Newly Discovered Feature of Hypericin and its Preclinical Applications in Necrosis Imaging
por: Jiang, Binghu, et al.
Publicado: (2013)

Improved therapeutic outcomes of thermal ablation on rat orthotopic liver allograft sarcoma models by radioiodinated hypericin induced necrosis targeted radiotherapy
por: Gao, Long, et al.
Publicado: (2016)

Towards Stratifying Ischemic Components by Cardiac MRI and Multifunctional Stainings in a Rabbit Model of Myocardial Infarction
por: Feng, Yuanbo, et al.
Publicado: (2013)

Lipomatous metaplasia identified in rabbits with reperfused myocardial infarction by 3.0 T magnetic resonance imaging and histopathology
por: Feng, Yuanbo, et al.
Publicado: (2013)

Discovery of Radioiodinated Monomeric Anthraquinones as a Novel Class of Necrosis Avid Agents for Early Imaging of Necrotic Myocardium
por: Wang, Qin, et al.
Publicado: (2016)

Multifunctional Nanoparticles as High-Efficient Targeted Hypericin System for Theranostic Melanoma
por: de Morais, Flávia Amanda Pedroso, et al.
Publicado: (2022)

Enhanced Antitumor Efficacy of a Vascular Disrupting Agent Combined with an Antiangiogenic in a Rat Liver Tumor Model Evaluated by Multiparametric MRI
por: Chen, Feng, et al.
Publicado: (2012)

A Model In Vitro Study Using Hypericin: Tumor-Versus Necrosis-Targeting Property and Possible Mechanisms
por: Li, Yue, et al.
Publicado: (2020)

Necrosis targeted radiotherapy with iodine-131-labeled hypericin to improve anticancer efficacy of vascular disrupting treatment in rabbit VX2 tumor models
por: Shao, Haibo, et al.
Publicado: (2015)

Elucidation of the tumoritropic principle of hypericin
por: Van de Putte, M, et al.
Publicado: (2005)

Molecular Theranostics in Radioiodine-Refractory Differentiated Thyroid Cancer
por: Petranović Ovčariček, Petra, et al.
Publicado: (2023)

Small Molecule Sequential Dual-Targeting Theragnostic Strategy (SMSDTTS): from Preclinical Experiments towards Possible Clinical Anticancer Applications
por: Li, Junjie, et al.
Publicado: (2013)

Vascular disrupting agent in pancreatic and hepatic tumour allografts: observations of location-dependent efficacy by MRI, microangiography and histomorphology
por: Yin, Ting, et al.
Publicado: (2017)

AI-based MRI auto-segmentation of brain tumor in rodents, a multicenter study
por: Wang, Shuncong, et al.
Publicado: (2023)

Evaluation of Radioiodinated Fluoronicotinamide/Fluoropicolinamide-Benzamide Derivatives as Theranostic Agents for Melanoma
por: Chen, Chao-Cheng, et al.
Publicado: (2020)

Radioiodinated Phenylalkyl Malonic Acid Derivatives as pH-Sensitive SPECT Tracers
por: Bauwens, Matthias, et al.
Publicado: (2012)

Personalized Medicine Based on Theranostic Radioiodine Molecular Imaging for Differentiated Thyroid Cancer
por: Ahn, Byeong-Cheol
Publicado: (2016)

Tumor necrosis targeted radiotherapy of non-small cell lung cancer using radioiodinated protohypericin in a mouse model
por: Liu, Xuejiao, et al.
Publicado: (2015)

Impact of Blood–Brain Barrier to Delivering a Vascular-Disrupting Agent: Predictive Role of Multiparametric MRI in Rodent Craniofacial Metastasis Models
por: Wang, Shuncong, et al.
Publicado: (2022)

Preclinical evaluation of carbon-11 and fluorine-18 sulfonamide derivatives for in vivo radiolabeling of erythrocytes
por: Gheysens, Olivier, et al.
Publicado: (2013)

Predicting Clinical Efficacy of Vascular Disrupting Agents in Rodent Models of Primary and Secondary Liver Cancers: An Overview with Imaging-Histopathology Correlation
por: Liu, Yewei, et al.
Publicado: (2020)

Visualization, Quantification and Characterization of Caerulein-Induced Acute Pancreatitis in Rats by 3.0T Clinical MRI, Biochemistry and Histomorphology
por: Yin, Ting, et al.
Publicado: (2017)

Hypericins as Potential Leads for New Therapeutics
por: Karioti, Anastasia, et al.
Publicado: (2010)

Everolimus halts hepatic cystogenesis in a rodent model of polycystic-liver-disease
por: Temmerman, Frederik, et al.
Publicado: (2017)

Theranostic Options for Radioiodine-Refractory Differentiated Thyroid Carcinoma: Recent Advances, Challenges, and Road Ahead
por: Satapathy, Swayamjeet, et al.
Publicado: (2022)

Hypericin-bearing magnetic iron oxide nanoparticles for selective drug delivery in photodynamic therapy
por: Unterweger, Harald, et al.
Publicado: (2015)

A photodynamic pathway to apoptosis and necrosis induced by dimethyl tetrahydroxyhelianthrone and hypericin in leukaemic cells: possible relevance to photodynamic therapy
por: Lavie, G, et al.
Publicado: (1999)

Theranostic role of radiolabelled RGD peptide in the treatment of radioiodine-resistant thyroid cancer: A novel agent
por: Vatsa, Rakhee, et al.
Publicado: (2020)

Hypericin in the Dark: Foe or Ally in Photodynamic Therapy?
por: Huntosova, Veronika, et al.
Publicado: (2016)

Transplacental passage of hyperforin, hypericin, and valerenic acid
por: Spiess, Deborah, et al.
Publicado: (2023)

Sequential Administrations of a Vascular-Disrupting Agent, High-Intensity Focused Ultrasound, and a Radioactively labeled Necrosis Avid Compound for Eradicating Solid Malignancies
por: Li, Yue, et al.
Publicado: (2022)

Micro-HCCs in rats with liver cirrhosis: paradoxical targeting effects with vascular disrupting agent CA4P
por: Liu, Yewei, et al.
Publicado: (2017)

Fabrication of Hypericin Imprinted Polymer Nanospheres via Thiol-Yne Click Reaction
por: Pei, Yuxin, et al.
Publicado: (2017)

Molecular profiling of angiogenesis in hypericin mediated photodynamic therapy
por: Bhuvaneswari, Ramaswamy, et al.
Publicado: (2008)

Photodynamic Effect of Hypericin on the Conformation and Catalytic Activity of Hemoglobin
por: Zhao, Jing, et al.
Publicado: (2008)

Hypericin in the Light and in the Dark: Two Sides of the Same Coin
por: Jendželovská, Zuzana, et al.
Publicado: (2016)

Hypericin, a potential new BH3 mimetic
por: Doroshenko, Anastasia, et al.
Publicado: (2022)

Facile fabrication of hypericin-entrapped glyconanoparticles for targeted photodynamic therapy
por: Shao, Chen, et al.
Publicado: (2018)

Analysis of Hypericin-Mediated Effects and Implications for Targeted Photodynamic Therapy
por: Mühleisen, Laura, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8b54cpij6pej0pbeumo19mrmgg